White-matter abnormalities in presymptomatic GRN and C9orf72 mutation carriers

被引:3
|
作者
Lee, Hyunwoo [1 ]
Mackenzie, Ian R. A. [2 ]
Beg, Mirza Faisal [3 ]
Popuri, Karteek [4 ]
Rademakers, Rosa [5 ,6 ,7 ]
Wittenberg, Dana [1 ]
Hsiung, Ging-Yuek Robin [1 ]
机构
[1] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 2B5, Canada
[2] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada
[3] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada
[4] Mem Univ Newfoundland, Dept Comp Sci, St John, NL A1B 3X5, Canada
[5] VIB, VIB Ctr Mol Neurol, Appl & Translat Neurogen, B-2610 Antwerp, Belgium
[6] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium
[7] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
frontotemporal dementia; MRI; white matter; GENETIC FRONTOTEMPORAL DEMENTIA; HUMAN CEREBRAL-CORTEX; GRAY-MATTER; BRAIN; PROGRANULIN; HYPERINTENSITIES; DEGENERATION; INTEGRITY; ATROPHY; GENFI;
D O I
10.1093/braincomms/fcac333
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lee et al. report that MRI-based white-matter abnormalities are more pronounced in presymptomatic GRN and C9orf72 mutation carriers, compared with family controls who do not carry the mutations. They suggest that white-matter changes may represent early markers of familial frontotemporal dementia associated with a genetic cause. A large proportion of familial frontotemporal dementia is caused by TAR DNA-binding protein 43 (transactive response DNA-binding protein 43 kDa) proteinopathies. Accordingly, carriers of autosomal dominant mutations in the genes associated with TAR DNA-binding protein 43 aggregation, such as Chromosome 9 open reading frame 72 (C9orf72) or progranulin (GRN), are at risk of later developing frontotemporal dementia. Brain imaging abnormalities that develop before dementia onset in mutation carriers may serve as proxies for the presymptomatic stages of familial frontotemporal dementia due to a genetic cause. Our study objective was to investigate brain MRI-based white-matter changes in predementia participants carrying mutations in C9orf72 or GRN genes. We analysed mutation carriers and their family member controls (noncarriers) from the University of British Columbia familial frontotemporal dementia study. First, a total of 42 participants (8 GRN carriers; 11 C9orf72 carriers; 23 noncarriers) had longitudinal T-1-weighted MRI over similar to 2 years. White-matter signal hypointensities were segmented and volumes were calculated for each participant. General linear models were applied to compare the baseline burden and the annualized rate of accumulation of signal abnormalities among mutation carriers and noncarriers. Second, a total of 60 participants (9 GRN carriers; 17 C9orf72 carriers; 34 noncarriers) had cross-sectional diffusion tensor MRI available. For each participant, we calculated the average fractional anisotropy and mean, radial and axial diffusivity parameter values within the normal-appearing white-matter tissues. General linear models were applied to compare whether mutation carriers and noncarriers had different trends in diffusion tensor imaging parameter values as they neared the expected age of onset. Baseline volumes of white-matter signal abnormalities were not significantly different among mutation carriers and noncarriers. Longitudinally, GRN carriers had significantly higher annualized rates of accumulation (estimated mean: 15.87%/year) compared with C9orf72 carriers (3.69%/year) or noncarriers (2.64%/year). A significant relationship between diffusion tensor imaging parameter values and increasing expected age of onset was found in the periventricular normal-appearing white-matter region. Specifically, GRN carriers had a tendency of a faster increase of mean and radial diffusivity values and C9orf72 carriers had a tendency of a faster decline of fractional anisotropy values as they reached closer to the expected age of dementia onset. These findings suggest that white-matter changes may represent early markers of familial frontotemporal dementia due to genetic causes. However, GRN and C9orf72 mutation carriers may have different mechanisms leading to tissue abnormalities.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Early structural alterations and longitudinal changes in presymptomatic carriers of the C9orf72 expansion
    Saracino, D.
    Guyot, A.
    Houot, M.
    Sayah, S.
    Funkiewiez, A.
    Rinaldi, D.
    Routier, A.
    Pasquier, F.
    Wallon, D.
    Couratier, P.
    Colliot, O.
    Le Ber, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 493 - 494
  • [22] Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype
    Floeter, Mary Kay
    Bageac, Devin
    Danielian, Laura E.
    Braun, Laura E.
    Traynor, Bryan J.
    Kwan, Justin Y.
    NEUROIMAGE-CLINICAL, 2016, 12 : 1035 - 1043
  • [23] Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort
    Van Mossevelde, Sara
    van der Zee, Julie
    Gijselinck, Ilse
    Engelborghs, Sebastiaan
    Sieben, Anne
    Van Langenhove, Tim
    De Bleecker, Jan
    Baets, Jonathan
    Vandenbulcke, Mathieu
    Van Laere, Koen
    Ceyssens, Sarah
    Van den Broeck, Marleen
    Peeters, Karin
    Mattheijssens, Maria
    Cras, Patrick
    Vandenberghe, Rik
    De Jonghe, Peter
    Martin, Jean-Jacques
    De Deyn, Peter P.
    Cruts, Marc
    Van Broeckhoven, Christine
    BRAIN, 2016, 139 : 452 - 467
  • [24] Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
    Frick, Petra
    Sellier, Chantal
    Mackenzie, Ian R. A.
    Cheng, Chieh-Yu
    Tahraoui-Bories, Julie
    Martinat, Cecile
    Pasterkamp, R. Jeroen
    Prudlo, Johannes
    Edbauer, Dieter
    Oulad-Abdelghani, Mustapha
    Feederle, Regina
    Charlet-Berguerand, Nicolas
    Neumann, Manuela
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 72
  • [25] Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
    Petra Frick
    Chantal Sellier
    Ian R. A. Mackenzie
    Chieh-Yu Cheng
    Julie Tahraoui-Bories
    Cecile Martinat
    R. Jeroen Pasterkamp
    Johannes Prudlo
    Dieter Edbauer
    Mustapha Oulad-Abdelghani
    Regina Feederle
    Nicolas Charlet-Berguerand
    Manuela Neumann
    Acta Neuropathologica Communications, 6
  • [26] Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers
    Peter Bede
    Dorothée Lulé
    Hans-Peter Müller
    Ee Ling Tan
    Johannes Dorst
    Albert C. Ludolph
    Jan Kassubek
    Journal of Neurology, 2023, 270 : 4235 - 4247
  • [27] Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers
    Bede, Peter
    Lule, Dorothee
    Mueller, Hans-Peter
    Tan, Ee Ling
    Dorst, Johannes
    Ludolph, Albert C.
    Kassubek, Jan
    JOURNAL OF NEUROLOGY, 2023, 270 (09) : 4235 - 4247
  • [28] Spinal Cord MRI for Early Detection of Presymptomatic Pathology in c9orf72 Mutation Carriers: A Longitudinal Neuroimaging Study
    Querin, Giorgia
    Bede, Peter
    El Mendili, Mounir
    Pellegrini-Issac, Melanie
    Rinaldi, Daisy
    Catala, Martin
    Saracino, Dario
    Salachas, Francois
    Camuzat, Agnes
    Marchand-Pauvert, Veronique
    Cohen-Adad, Julien
    Colliot, Olivier
    Le Ber, Isabelle
    Pradat, Pierre-Francois
    NEUROLOGY, 2020, 94 (15)
  • [29] Spinal cord MRI for early detection of presymptomatic pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study
    Querin, G.
    Bede, P.
    El Mendili, M.
    Pellegrini-Issac, M.
    Rinaldi, D.
    Catala, M.
    Saracino, D.
    Salachas, F.
    Camuzat, A.
    Marchand-Pauvert, V.
    Cohen-Adad, J.
    Colliot, O.
    Le Ber, I.
    Pradat, P.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S148 - S148
  • [30] Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
    De Vocht, Joke
    Blommaert, Jeroen
    Devrome, Martijn
    Radwan, Ahmed
    Van Weehaeghe, Donatienne
    De Schaepdryver, Maxim
    Ceccarini, Jenny
    Rezaei, Ahmadreza
    Schramm, Georg
    van Aalst, June
    Chio, Adriano
    Pagani, Marco
    Stam, Daphne
    Van Esch, Hilde
    Lamaire, Nikita
    Verhaegen, Marianne
    Mertens, Nathalie
    Poesen, Koen
    van den Berg, Leonard H.
    van Es, Michael A.
    Vandenberghe, Rik
    Vandenbulcke, Mathieu
    Van den Stock, Jan
    Koole, Michel
    Dupont, Patrick
    Van Laere, Koen
    Van Damme, Philip
    JAMA NEUROLOGY, 2020, 77 (08) : 1008 - 1017